Sertoli cell tumor of the ovary. A case report

Authors

Keywords:

Sertoli cell tumor of the ovary, immunohistochemical techniques, correct immunohistochemistry, accurate pathological diagnosis.

Abstract

Introduction: Sertoli cell tumors are a rare entity with an incidence of ovarian cancer of 0,2-0,5 %. The initial diagnosis of this type of tumors is difficult to make due to the histological varieties and its differentiation.

Objective: To demonstrate the value of immunochemical techniques in the completion of the diagnostic process of ovarian tumors aimed at identifying a rare variant such as Sertoli cell tumor.

Case presentation: A 43-year old woman with a primitive Sertoli cell tumor of the ovary is presented. The patient had personal history of hypothyroidism. She underwent surgery at “Dr. Agostinho Neto” General Teaching Hospital because she had been diagnosed with a solid tumor of the right ovary. During the intraoperative period, a giant tumor with a malignant appearance was found. The pathological result reported a typical carcinoid tumor. The patient was referred to the National Institute of Oncology and Radiobiology where the immunohistochemistry of the biopsy reported a Sertoli cell tumor. Currently, the patient is asymptomatic.

Conclusions: The accurate pathological diagnosis and the correct immunohistochemistry are very important for the management and treatment of this type of tumor.

Downloads

Download data is not yet available.

Author Biographies

Raquel Duran Bornot, Instituto Nacional de Oncología y Radiobiología (INOR). Universidad de Ciencias Médicas de La Habana. La Habana.

Especialista Primer Grado en Ginecología, Master en atención integral a la mujer en Ginecología, Profesor Asistente.

Shivani Samlall, Instituto Nacional de Oncología y Radiobiología (INOR).

Especialista en Ginecología. Diplomado en Oncología.

Maydelín Frontela Noda, Instituto Nacional de Oncología y Radiobiología (INOR). Universidad de Ciencias Médicas de La Habana. La Habana.

Lic en Bioquímica, Master en Bioquímica (Mención Bioquímica Clínica). Investigador Auxiliar, Profesor Asistente.

References

1. Correa R, Cuello M, Gejman R, Merino P, Etchegaray A, Carrasco M, et al. Tumor de Células de Sertoli y Leydig del ovario. Rev Chilena Obstetr Ginecol. 2003; 68(5):399-406.

2. Fleckenstein G, Sattler B, Hinney B, Wuttke W, Osmers R, Emons G. Androblastoma of the ovary: Clinical diagnosis, histopathologic features. Onkologie. 2001;24(3):286-9.

3. Qiong Xu, Yu Zou, Xiao Fei Zhang. Sertoli–Leydig cell tumors of ovary. A case series. Medicine. 2018;97:42.

4. Zaid AA, Azzam A, Alghuneim LA, Metawee MT, Tarek A, Al-Hussain TO. Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor in a 16-Year-Old Single Woman: A Case Report and Literature Review. Obstetrics and Gynecology [Internet]. 2013 [Citado 05/08/2019];1:[aprox. 2 p.]. Disponible en: http://dx.doi.org/10.1155/2013/858501

5. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors with a retiform pattern: a problem in histopathologic diagnosis. A report of 25 cases. Am J Surg Pathol. 1983; 7:755-71.

6. Chen L, Tunnell CD, De Petris G. Sertoli-Leydig Cell tumor with heterologous element. A case report and review of the literature. Int J Clin Exp Pathol. 2014; 1176-81.

7. DiSaia PJ, Creasman WT. The adnexal mass and early ovarian cancer. Clinical Gynecologic Oncology. 6 ed. St. Louis: Mosby Inc; 2002.

8. Sandoval Díaz I, Hernández Alarcón R, Torres Arones E, Latorre Zúñiga A. Tumor de Células de Sertoli-Leydig: A propósito de un caso. Rev Peru Ginecol Obstet. 2014;60(3):245-9.

9. Iczkowski KA, Bostwick DG, Roche PC, Cheville JC.:Inhibin A is a sensitive marker for testicular sex cord-stromal tumors. Mod Pathol. 1998 Aug; 11(8):774-9.

10. Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol. 2012;127(2):384-9.

11. Grove A, Vestergaard V. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature. Ann Diagn Pathol. 2006;10(5):288-93.

12. Weng CS, Chen MY, Wang TY, Tsai HW, Hung YC, Yu KJ, et al. Sertoli-Leydig cell tumors of the ovary: a Taiwanese Gynecologic Oncology Group study. Taiwan J Obstet Gynecol. 2013;52(1):66-70.

13. Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, et al. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study. Gynecol Oncol. 2012;125(3):673-6.

14. ML A, AQ M, GM M, Rendón G, Pareja R. Tumores virilizantes del ovario: presentación de dos casos manejados mediante cirugía por monopuerto. Rev Chil Obstet Ginecol. 2015;80(2):156-160.

15. Gupta MM, Bahri NU, Ketan R. Sortoli-Leydig Cell Tumor of the Ovary in a Young Female: A Case Report and Literature Review. Saudi Journal of Medicine & Medical Sciences. 2015;3(3):233-7.

16. Akman L, Ertas IE, Gokcu M, Terek MC, Sanci M, Sanli UA, Zekioglu O, Ozsaran AA. Ovarian sertoli–leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients. J Can Res Ther. 2016;12(1):290-4.

17. León Álvarez M, González Valcárcel K, Rodríguez Santos CI. Tumor de células de Sertoli-Leydig de ovario. Presentación de una paciente. Medicent Electrón. 2015;19(1):42-45.

Published

2020-05-01

How to Cite

1.
Duran Bornot R, Samlall S, Frontela Noda M. Sertoli cell tumor of the ovary. A case report. Rev haban cienc méd [Internet]. 2020 May 1 [cited 2025 Aug. 21];19(2):e2945. Available from: https://revhabanera.sld.cu/index.php/rhab/article/view/2945

Issue

Section

Clinical and pathological sciences